176 related articles for article (PubMed ID: 24224111)
1. Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease.
Brewer GJ; Kaur S
Int J Alzheimers Dis; 2013; 2013():586365. PubMed ID: 24224111
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease causation by copper toxicity and treatment with zinc.
Brewer GJ
Front Aging Neurosci; 2014; 6():92. PubMed ID: 24860501
[TBL] [Abstract][Full Text] [Related]
3. Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease.
Brewer GJ
Biofactors; 2012; 38(2):107-13. PubMed ID: 22438177
[TBL] [Abstract][Full Text] [Related]
4. Copper toxicity in Alzheimer's disease: cognitive loss from ingestion of inorganic copper.
Brewer GJ
J Trace Elem Med Biol; 2012 Jun; 26(2-3):89-92. PubMed ID: 22673823
[TBL] [Abstract][Full Text] [Related]
5. Divalent Copper as a Major Triggering Agent in Alzheimer's Disease.
Brewer GJ
J Alzheimers Dis; 2015; 46(3):593-604. PubMed ID: 25854930
[TBL] [Abstract][Full Text] [Related]
6. Copper-2 Ingestion, Plus Increased Meat Eating Leading to Increased Copper Absorption, Are Major Factors Behind the Current Epidemic of Alzheimer's Disease.
Brewer GJ
Nutrients; 2015 Dec; 7(12):10053-64. PubMed ID: 26633489
[TBL] [Abstract][Full Text] [Related]
7. Copper-2 Hypothesis for Causation of the Current Alzheimer's Disease Epidemic Together with Dietary Changes That Enhance the Epidemic.
Brewer GJ
Chem Res Toxicol; 2017 Mar; 30(3):763-768. PubMed ID: 28161940
[TBL] [Abstract][Full Text] [Related]
8. Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer's disease and protection effects of zinc and fluvastatin.
Yao D; Jing T; Niu L; Huang X; Wang Y; Deng X; Wang M
Brain Res Bull; 2018 Oct; 143():1-8. PubMed ID: 30227236
[TBL] [Abstract][Full Text] [Related]
9. Zinc and Copper in Alzheimer's Disease.
Avan A; Hoogenraad TU
J Alzheimers Dis; 2015; 46(1):89-92. PubMed ID: 25835420
[TBL] [Abstract][Full Text] [Related]
10. Zinc Therapy in Early Alzheimer's Disease: Safety and Potential Therapeutic Efficacy.
Squitti R; Pal A; Picozza M; Avan A; Ventriglia M; Rongioletti MC; Hoogenraad T
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784855
[TBL] [Abstract][Full Text] [Related]
11. Avoiding Alzheimer's disease: The important causative role of divalent copper ingestion.
Brewer GJ
Exp Biol Med (Maywood); 2019 Feb; 244(2):114-119. PubMed ID: 30727765
[TBL] [Abstract][Full Text] [Related]
12. Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.
Wang ZX; Tan L; Wang HF; Ma J; Liu J; Tan MS; Sun JH; Zhu XC; Jiang T; Yu JT
J Alzheimers Dis; 2015; 47(3):565-81. PubMed ID: 26401693
[TBL] [Abstract][Full Text] [Related]
13. Dietary Habits, Selenium, Copper, Zinc and Total Antioxidant Status in Serum in Relation to Cognitive Functions of Patients with Alzheimer's Disease.
Socha K; Klimiuk K; Naliwajko SK; Soroczyńska J; Puścion-Jakubik A; Markiewicz-Żukowska R; Kochanowicz J
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498452
[TBL] [Abstract][Full Text] [Related]
14. The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease.
Brewer GJ
J Am Coll Nutr; 2009 Jun; 28(3):238-42. PubMed ID: 20150596
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease.
Molina JA; Jiménez-Jiménez FJ; Aguilar MV; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Porta J; Ortí-Pareja M; Zurdo M; Barrios E; Martínez-Para MC
J Neural Transm (Vienna); 1998; 105(4-5):479-88. PubMed ID: 9720975
[TBL] [Abstract][Full Text] [Related]
16. Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies.
Ventriglia M; Brewer GJ; Simonelli I; Mariani S; Siotto M; Bucossi S; Squitti R
J Alzheimers Dis; 2015; 46(1):75-87. PubMed ID: 25697706
[TBL] [Abstract][Full Text] [Related]
17. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
Park JH; Lee DW; Park KS
Asia Pac Psychiatry; 2014 Mar; 6(1):38-45. PubMed ID: 23857910
[TBL] [Abstract][Full Text] [Related]
19. Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease.
Moynier F; Borgne ML; Lahoud E; Mahan B; Mouton-Liger F; Hugon J; Paquet C
Alzheimers Dement (Amst); 2020; 12(1):e12112. PubMed ID: 33102682
[TBL] [Abstract][Full Text] [Related]
20. Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies.
Graham SF; Nasaruddin MB; Carey M; Holscher C; McGuinness B; Kehoe PG; Love S; Passmore P; Elliott CT; Meharg AA; Green BD
J Alzheimers Dis; 2014; 42(4):1407-13. PubMed ID: 25024342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
